These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 27804883)

  • 1. Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders.
    Suryadevara U; Bruijnzeel DM; Nuthi M; Jagnarine DA; Tandon R; Bruijnzeel AW
    Curr Neuropharmacol; 2017; 15(6):800-814. PubMed ID: 27804883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
    Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis-based medicines for chronic neuropathic pain in adults.
    Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.
    Belendiuk KA; Baldini LL; Bonn-Miller MO
    Addict Sci Clin Pract; 2015 Apr; 10():10. PubMed ID: 25896576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature.
    Inglet S; Winter B; Yost SE; Entringer S; Lian A; Biksacky M; Pitt RD; Mortensen W
    Ann Pharmacother; 2020 Nov; 54(11):1109-1143. PubMed ID: 32483988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial.
    Urbi B; Broadley S; Bedlack R; Russo E; Sabet A
    BMJ Open; 2019 Nov; 9(11):e029449. PubMed ID: 31719072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.
    Breijyeh Z; Jubeh B; Bufo SA; Karaman R; Scrano L
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33562446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive and Negative Effects of Cannabis and Cannabinoids on Health.
    Cohen K; Weizman A; Weinstein A
    Clin Pharmacol Ther; 2019 May; 105(5):1139-1147. PubMed ID: 30703255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
    Weinkle L; Domen CH; Shelton I; Sillau S; Nair K; Alvarez E
    Mult Scler Relat Disord; 2019 Jan; 27():383-390. PubMed ID: 30502644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis for the treatment of Crohn's disease.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and correlates of medical cannabis patients' use of cannabis for recreational purposes.
    Morean ME; Lederman IR
    Addict Behav; 2019 Jun; 93():233-239. PubMed ID: 30772776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.
    Parmar JR; Forrest BD; Freeman RA
    Res Social Adm Pharm; 2016; 12(4):638-54. PubMed ID: 26443472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical cannabis: What practitioners need to know.
    Van Rensburg R; Pillay-Fuentes Lorente V; Blockman M; Moodley K; Wilmshurst JM; Decloedt EH
    S Afr Med J; 2020 Feb; 110(3):192-196. PubMed ID: 32657695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
    Sarris J; Sinclair J; Karamacoska D; Davidson M; Firth J
    BMC Psychiatry; 2020 Jan; 20(1):24. PubMed ID: 31948424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological Disorders in Medical Use of Cannabis: An Update.
    Solimini R; Rotolo MC; Pichini S; Pacifici R
    CNS Neurol Disord Drug Targets; 2017; 16(5):527-533. PubMed ID: 28412919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis and neuropsychiatry, 1: benefits and risks.
    Andrade C
    J Clin Psychiatry; 2016 May; 77(5):e551-4. PubMed ID: 27249079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis and schizophrenia.
    McLoughlin BC; Pushpa-Rajah JA; Gillies D; Rathbone J; Variend H; Kalakouti E; Kyprianou K
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004837. PubMed ID: 25314586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical use of cannabis: an addiction medicine perspective.
    Cook J; Lloyd-Jones DM; Ogden E; Bonomo Y
    Intern Med J; 2015 Jun; 45(6):677-80. PubMed ID: 26059881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.